Nuzenio

Treatment Patents

Treatment Patents news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

After Hikma: Skinny Labels, Inducement and the Future of Method-of-Treatment Patents - IPWatchdog.comIPWatchdog.com · Fri, 07 Aug 2026 20:16:37 GMT Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 12:40:48 GMT Vivos sleep apnea devices gain broader protection after new patent - Stock TitanStock Titan · Wed, 05 Aug 2026 12:30:00 GMT Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 12:15:00 GMT Autonomix patent covers mapping nerves tied to tumors and cancer pain - Stock TitanStock Titan · Tue, 04 Aug 2026 12:15:00 GMT Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease - Business WireBusiness Wire · Wed, 29 Jul 2026 12:30:00 GMT

Timeline

Fri, 07 Aug 2026 20:16:37 GMTAfter Hikma: Skinny Labels, Inducement and the Future of Method-of-Treatment Patents - IPWatchdog.com

Wed, 05 Aug 2026 12:40:48 GMTVivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology - The Manila Times

Wed, 05 Aug 2026 12:30:00 GMTVivos sleep apnea devices gain broader protection after new patent - Stock Titan

Tue, 04 Aug 2026 12:15:00 GMTAutonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy - GlobeNewswire

Tue, 04 Aug 2026 12:15:00 GMTAutonomix patent covers mapping nerves tied to tumors and cancer pain - Stock Titan

Wed, 29 Jul 2026 12:30:00 GMTAlpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease - Business Wire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

After Hikma2 live mentions Skinny Labels2 live mentions Inducement2 live mentions Future2 live mentions Method2 live mentions IPWatchdog2 live mentions Vivos Therapeutics Announces2 live mentions Issuance2 live mentions New US Patent2 live mentions Broadening Protection2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Treatment Patents.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.